The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Molecular pathogenesis of retinal and choroidal vascular diseases
Open accessAbstract
There are two major types of ocular neovascularization that affect the retina, retinal neovascularization (NV) and subretinal or choroidal NV. Retinal NV occurs in a group of diseases referred to as ischemic retinopathies in which damage to retinal vessels results in retinal ischemia. Most prevalent of these are diabetic retinopathy and retinal vein occlusions. Subretinal and choroidal NV occur in diseases of the outer retina and Bruch’s membrane, the most prevalent of which is age-related macular degeneration. Numerous studies in mouse models have helped to elucidate the molecular pathogenesis underlying retinal, subretinal, and choroidal NV. There is considerable overlap because the precipitating event in each is stabilization of hypoxia inducible factor-1 (HIF-1) which leads to upregulation of several hypoxia-regulated gene products, including vascular endothelial growth factor (VEGF), angiopoietin 2, vascular endothelial-protein tyrosine phosphatase (VE-PTP), and several others. Stimulation of VEGF signaling and suppression of Tie2 by angiopoietin 2 and VE-PTP are critical for sprouting of retinal, subretinal, and choroidal NV, with perturbation of Bruch’s membrane also needed for the latter. Additional HIF-1-regulated gene products cause further stimulation of the NV. It is difficult to model macular edema in animals and therefore proof-of-concept clinical trials were done and demonstrated that VEGF plays a central role and that suppression of Tie2 is also important. Neutralization of VEGF is currently the first line therapy for all of the above disease processes, but new treatments directed at some of the other molecular targets, particularly stabilization of Tie2, are likely to provide additional benefit for subretinal/choroidal NV and macular edema. In addition, the chronicity of these diseases as well as the implication of VEGF as a cause of retinal nonperfusion and progression of background diabetic retinopathy make sustained delivery approaches for VEGF antagonists a priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lee, K., Qian, D. Z., Rey, S., Wei, H., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812801106 · Cited by 289
RetractedRanibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226 · cited 1×
“The expression of PDGF-B is increased by hypoxia, predominantly in vascular endothelial cells and is important for pericyte recruitment; mice deficient in PDGF-B have poor pericyte coverage of retinal vessels which are leaky (Betsholtz, 2004; Lindahl et al., 1997; Lindblom et al., 2003).”
BackgroundIsolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,820
Oxygen-induced retinopathy in the mouse.
Smith, L. E. H., Wesolowski, E., McLellan, A., Kostyk, S. K., D’Amato, R. J., Sullivan, R., & D'Amore, P. A. (1994) · PubMed · Cited by 1,627
Ranibizumab for Diabetic Macular Edema
Nguyen, Q. D., Brown, D. M., Marcus, D. M., Boyer, D. S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A. C., Hopkins, J. J., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.039 · Cited by 1,621
Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., & Keshet, E. (1995) · Nature Medicine · doi:10.1038/nm1095-1024 · Cited by 1,604
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H.-J., Benedict, W., & Bouck, N. P. (1999) · Science · doi:10.1126/science.285.5425.245 · Cited by 1,505
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.031 · Cited by 1,428
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marme, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,356
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
Brown, D. M., Campochiaro, P. A., Singh, R. P., Li, Z., Gray, S., Saroj, N., Rundle, A. C., Rubio, R. G., & Murahashi, W. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.022 · Cited by 1,155
Self-citationPark, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,018
Self-citationStone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T., & Keshet, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-04738.1995 · Cited by 1,006
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion
Campochiaro, P. A., Heier, J. S., Feiner, L., Gray, S., Saroj, N., Rundle, A. C., Murahashi, W. Y., & Rubio, R. G. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.021 · Cited by 818
Self-citationVEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
Kamba, T., Tam, B. Y. Y., Hashizume, H., Haskell, A., Sennino, B., Mancuso, M. R., Norberg, S. M., O'Brien, S. M., Davis, R. B., Gowen, L. C., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00133.2005 · Cited by 775
Inai, T., Mancuso, M., Hashizume, H., Baffert, F., Haskell, A., Baluk, P., Hu-Lowe, D. D., Shalinsky, D. R., Thurston, G., Yancopoulos, G. D., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63273-7 · Cited by 757
Campochiaro, P. A., Brown, D. M., Awh, C. C., Lee, S. Y., Gray, S., Saroj, N., Murahashi, W. Y., & Rubio, R. G. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.038 · Cited by 711
Self-citationRETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION
Yannuzzi, L. A., Negrão, S., IIDA, T., Carvalho, C., Rodriguez-Coleman, H., Slakter, J., Freund, K. B., Sorenson, J., Orlock, D., & Borodoker, N. (2012) · Retina · doi:10.1097/iae.0b013e31823f9b3b · Cited by 660
RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATION
YANNUZZI, L. A., NEGRÃO, S., IIDA, T., CARVALHO, C., RODRIGUEZ-COLEMAN, H., SLAKTER, J., FREUND, K. B., SORENSON, J., ORLOCK, D., & BORODOKER, N. (2001) · Retina · doi:10.1097/00006982-200110000-00003 · Cited by 659
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall
Lindblom, P., Gerhardt, H., Liebner, S., Abramsson, A., Enge, M., Hellström, M., Bäckström, G., Fredriksson, S., Landegren, U., Nyström, H. C., et al. (2003) · Genes & Development · doi:10.1101/gad.266803 · Cited by 657
Weber, B. H. F., Vogt, G., Pruett, R. C., Stöhr, H., & Felbor, U. (1994) · Nature Genetics · doi:10.1038/ng1294-352 · Cited by 656
Kim, I., Kim, H. G., So, J.-N., Kim, J. H., Kwak, H. J., & Koh, G. Y. (2000) · Circulation Research · doi:10.1161/01.res.86.1.24 · Cited by 649
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809763105 · Cited by 624 · cited 2×
“High throughput screening of a drug library with a reporter cell line for HIF-1 transcriptional activity has determined that digoxin and doxorubicin are strong inhibitors of HIF-1 activity (Lee et al., 2009; Zhang et al., 2008).”
BackgroundKelly, B. D., Hackett, S. F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P. A., & Semenza, G. L. (2003) · Circulation Research · doi:10.1161/01.res.0000102937.50486.1b · Cited by 611
Self-citationRisk of geographic atrophy in the comparison of age-related macular degeneration treatments trials
Grunwald, J. E., Daniel, E., Huang, J., Ying, G.-S., Maguire, M. G., Toth, C. A., Jaffe, G. J., Fine, S. L., Blodi, B., Klein, M. L., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.08.015 · Cited by 590
Krzystolik, M. G. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.3.338 · Cited by 590
An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris
Saint-Geniez, M., Kurihara, T., Sekiyama, E., Maldonado, A. E., & D'Amore, P. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905010106 · Cited by 530
Campochiaro, P. A., Brown, D. M., Pearson, A., Chen, S., Boyer, D., Ruiz-Moreno, J., Garretson, B., Gupta, A., Hariprasad, S. M., Bailey, C., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.030 · Cited by 517
Self-citationRegulation of Vascular Endothelial Growth Factor by Oxygen in a Model of Retinopathy of Prematurity
Pierce, E. A. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140419009 · Cited by 506
Ranibizumab for Macular Edema Due to Retinal Vein Occlusions
Heier, J. S., Campochiaro, P. A., Yau, L., Li, Z., Saroj, N., Rubio, R. G., & Lai, P. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.005 · Cited by 470
Self-citationBrown, D. M., Campochiaro, P. A., Bhisitkul, R. B., Ho, A. C., Gray, S., Saroj, N., Adamis, A. P., Rubio, R. G., & Murahashi, W. Y. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.022 · Cited by 465
Self-citationAliello, L. P. (1995) · Medical Entomology and Zoology · Cited by 463
VEGF is major stimulator in model of choroidal neovascularization.
Kwak, N., Okamoto, N., Wood, J. M., & Campochiaro, P. A. (2000) · PubMed · Cited by 442
Self-citationInsight into the physiological functions of PDGF through genetic studies in mice
Betsholtz, C. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.005 · Cited by 437
Structural diversity and evolution of human receptor-like protein tyrosine phosphatases.
Krueger, N. X., Streuli, M., & Saito, H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07523.x · Cited by 423
Campochiaro, P. A., Brown, D. M., Pearson, A., Ciulla, T., Boyer, D., Holz, F. G., Tolentino, M., Gupta, A., Duarte, L., Madreperla, S., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.12.028 · Cited by 405
Self-citationOzaki, H., Yu, A. Y., Della, N. G., Ozaki, K., Luna, J. D., Yamada, H., Hackett, S. F., Okamoto, N., Zack, D. J., Semenza, G. L., et al. (1999) · PubMed · Cited by 391
Self-citationAvery, R. L., Castellarin, A. A., Steinle, N. C., Dhoot, D. S., Pieramici, D. J., See, R., Couvillion, S., Nasir, M. A., Rabena, M. D., Le, K., et al. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305252 · Cited by 382
ANCHOR STUDY GROUP. RANIBIZUMAB VERSUS VERTEPORFIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Brown, D., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., & Kim, R. Y. (2006) · Cited by 382
Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
Yuan, H. T., Khankin, E. V., Karumanchi, S. A., & Parikh, S. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01472-08 · Cited by 373
Okamoto, N., Tobe, T., Hackett, S. F., Ozaki, H., Vinores, M. A., La Rochelle, W., Zack, D. J., & Campochiaro, P. A. (1998) · Retina · doi:10.1097/00006982-199805000-00034 · Cited by 365
Self-citationLack of collagen XVIII/endostatin results in eye abnormalities
Fukai, N. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1535 · Cited by 359
Marneros, A. G., Fan, J., Yokoyama, Y., Gerber, H. P., Ferrara, N., Crouch, R. K., & Olsen, B. R. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61231-x · Cited by 358
Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema
Nguyen, Q. D., Tatlipinar, S., Shah, S. M., Haller, J. A., Quinlan, E., Sung, J., Zimmer-Galler, I., Do, D. V., & Campochiaro, P. A. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.06.068 · Cited by 351
Self-citationOzaki, H., Seo, M.-S., Ozaki, K., Yamada, H., Yamada, E., Okamoto, N., Hofmann, F., Wood, J. M., & Campochiaro, P. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64773-6 · Cited by 347
Self-citationCampochiaro, P. A., Nguyen, Q. D., Shah, S. M., Klein, M. L., Holz, E., Frank, R. N., Saperstein, D. A., Gupta, A., Stout, J. T., Macko, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.167 · Cited by 343
Self-citationNguyen, Q. D., Shah, S. M., Heier, J. S., Do, D. V., Lim, J., Boyer, D., Abraham, P., & Campochiaro, P. A. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.04.023 · Cited by 340
Self-citationPigment epithelium‐derived factor inhibits retinal and choroidal neovascularization
Mori, K., Duh, E., Gehlbach, P., Ando, A., Takahashi, K., Pearlman, J., Mori, K., Yang, H. S., Zack, D. J., Ettyreddy, D., et al. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1114 · Cited by 337
Self-citationTolentino, M. J. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140172010 · Cited by 332
Targeted deletion of Vegfa in adult mice induces vision loss
Kurihara, T., Westenskow, P. D., Bravo, S., Aguilar, E., & Friedlander, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65157 · Cited by 328
Targeted Disruption of the FGF2 Gene Does Not Prevent Choroidal Neovascularization in a Murine Model
Tobe, T., Ortega, S., Luna, J. D., Ozaki, H., Okamoto, N., Derevjanik, N. L., Vinores, S. A., Basilico, C., & Campochiaro, P. A. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65753-7 · Cited by 325
Self-citationCampochiaro, P. A., Hafiz, G., Shah, S. M., Nguyen, Q. D., Ying, H., Do, D. V., Quinlan, E., Zimmer-Galler, I., Haller, J. A., Solomon, S. D., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.10 · Cited by 321
Self-citationNew Functions for Non-collagenous Domains of Human Collagen Type IV
Petitclerc, E., Boutaud, A., Prestayko, A., Xu, J., Sado, Y., Ninomiya, Y., Sarras, M. P., Hudson, B. G., & Brooks, P. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8051 · Cited by 315
Kim, I., Kim, J.-H., Moon, S.-O., Kwak, H. J., Kim, N.-G., & Koh, G. Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203800 · Cited by 306
Davis, A. A., Bernstein, P. S., Bok, D., Turner, J., Nachtigal, M., & Hunt, R. C. (1995) · PubMed · Cited by 272
OZAKI, H., HAYASHI, H., VINORES, S. A., MOROMIZATO, Y., CAMPOCHIARO, P. A., & OSHIMA, K. (1997) · Experimental Eye Research · doi:10.1006/exer.1996.0239 · Cited by 260
Self-citationSaishin, Y., Saishin, Y., Takahashi, K., Silva, R. L. E., Hylton, D., Rudge, J. S., Wiegand, S. J., & Campochiaro, P. A. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10246 · Cited by 239
Self-citationOxygen Studies in Retrolental Fibroplasia
Patz, A., Eastham, A., Higginbotham, D. H., & Kleh, T. (1953) · American Journal of Ophthalmology · doi:10.1016/0002-9394(53)91779-6 · Cited by 233
Mori, K., Gehlbach, P. L., Yamamoto, S., Duh, E. J., Zack, D. J., Li, Q., Berns, K. I., Raisler, B. J., Hauswirth, W. W., & Campochiaro, P. A. (2002) · PubMed · Cited by 231
Self-citationRetinal Precursors and the Development of Geographic Atrophy in Age-Related Macular Degeneration
Klein, M. L., Ferris, F. L., Armstrong, J., Hwang, T. S., Chew, E. Y., Bressler, S. B., & Chandra, S. R. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.08.030 · Cited by 225
Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature
Shen, J., Frye, M., Lee, B. L., Reinardy, J. L., McClung, J. M., Ding, K., Kojima, M., Xia, H., Seidel, C., Silva, R. L. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74527 · Cited by 217
Self-citationOkamoto, N., Tobe, T., Hackett, S. F., Ozaki, H., Vinores, M. A., LaRochelle, W. J., Zack, D. J., & Campochiaro, P. A. (1997) · Europe PMC (PubMed Central) · Cited by 212
Self-citationSubretinal Neovascularization: Natural History of an Experimental Model
Ryan, S. J. (1982) · Archives of Ophthalmology · doi:10.1001/archopht.1982.01030040784015 · Cited by 212
Angiopoietin‐2 plays an important role in retinal angiogenesis
Hackett, S. F., Wiegand, S., Yancopoulos, G., & Campochiaro, P. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10128 · Cited by 199
Self-citationMori, K., Gehlbach, P. L., Ando, A., McVey, D., Wei, L. L., & Campochiaro, P. A. (2002) · PubMed · Cited by 195
Self-citationFachinger, G., Deutsch, U., & Risau, W. (1999) · Oncogene · doi:10.1038/sj.onc.1202992 · Cited by 180
Supplemental Oxygen Improves Diabetic Macular Edema: A Pilot Study
Nguyen, Q. D., Shah, S. M., Van Anden, E., Sung, J. U., Vitale, S., & Campochiaro, P. A. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0557 · Cited by 178
Self-citationHackett, S. F., Ozaki, H., Strauss, R. W., Wahlin, K., Suri, C., Maisonpierre, P., Yancopoulos, G., & Campochiaro, P. A. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200009)184:3<275::aid-jcp1>3.0.co;2-7 · Cited by 176
Self-citationAndo‐Akatsuka, Y., Yonemura, S., Itoh, M., Furuse, M., & Tsukita, S. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199905)179:2<149::aid-jcp5>3.0.co;2-2 · Cited by 175
Tobe, T., Okamoto, N., Vinores, M. A., Derevjanik, N. L., Vinores, S. A., Zack, D. J., & Campochiaro, P. A. (1998) · PubMed · Cited by 171
Self-citationMousa, S. A., Lorelli, W., & Campochiaro, P. A. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990701)74:1<135::aid-jcb15>3.0.co;2-# · Cited by 171
Self-citationA New Model of Experimental Choroidal Neovascularization in the Rat
Dobi, E. T. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070010270035 · Cited by 166
Ohno-Matsui, K., Hirose, A., Yamamoto, S., Saikia, J., Okamoto, N., Gehlbach, P., Duh, E. J., Hackett, S., Chang, M., Bok, D., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64891-2 · Cited by 163
Self-citationIntraretinal oxygen levels before and after photoreceptor loss in the RCS rat.
Yu, D., Cringle, S. J., Su, E. N., et al. (2000) · PubMed · Cited by 160
Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1
Bainbridge, J. W., Mistry, A., de Alwis, M., Paleolog, E. M., Baker, A. H., Thrasher, A. J., & Ali, R. R. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301680 · Cited by 156
Mori, K., Ando, A., Gehlbach, P. L., Nesbitt, D. J., Takahashi, K., Goldsteen, D., Penn, M., Chen, C. T., Mori, K., Melia, M. B., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61697-5 · Cited by 155
Self-citationSilva, R. L. E., Shen, J., Hackett, S. F., Kachi, S., Akiyama, H., Kiuchi, K., Yokoi, K., Hatara, M. C., Lauer, T., Aslam, S., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7359com · Cited by 152
Self-citationReduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412
Campochiaro, P. A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0955 · Cited by 144
Self-citationAuricchio, A., Behling, K. C., Maguire, A. M., O'Connor, E. E., Bennett, J., Wilson, J. M., & Tolentino, M. J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0702 · Cited by 137
Oshima, Y., Oshima, S. M., Nambu, H., Kachi, S., Takahashi, K., Umeda, N., Shen, J., Dong, A., Apte, R. S., Duh, E. J., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2209fje · Cited by 132
Self-citationTakahashi, K., Saishin, Y., Saishin, Y., Silva, R. L., Oshima, Y., Oshima, S. M., Melia, M., Paszkiet, B., Zerby, D., Kadan, M. J., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0824fje · Cited by 131
Self-citationLai, C., Shen, W.-Y., Brankov, M., Lai, Y. K. Y., Barnett, N. L., Lee, S., Yeo, I. Y. S., Mathur, R., Ho, J. E., Pineda, P., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.022 · Cited by 124
Thrombosis associated with angiogenesis inhibitors
Elice, F., Rodeghiero, F., Falanga, A., & Rickles, F. R. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.01.001 · Cited by 123
Lai, Y., Shen, W., Brankov, M., Lai, C., Constable, I. J., & Rakoczy, P. E. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301695 · Cited by 120
Digoxin inhibits retinal ischemia‐induced HIF‐1α expression and ocular neovascularization
Yoshida, T., Zhang, H., Iwase, T., Shen, J., Semenza, G. L., & Campochiaro, P. A. (2010) · The FASEB Journal · doi:10.1096/fj.09-145664 · Cited by 119
Self-citationAngiopoietin 1 inhibits ocular neovascularization and breakdown of the blood–retinal barrier
Nambu, H., Nambu, R., Oshima, Y., Hackett, S. F., Okoye, G., Wiegand, S. J., Yancopoulos, G. D., Zack, D. J., & Campochiaro, P. A. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302230 · Cited by 115
Self-citationRaisler, B. J., Berns, K. I., Grant, M. B., Beliaev, D. V., & Hauswirth, W. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122247299 · Cited by 113
Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin.
Lai, C., Wu, W., Chen, S. L., Xiao, X., Tsai, T. C., Huan, S.-J., Chen, T.-L., Tsai, R. J.-F., & Tsao, Y. (2001) · PubMed · Cited by 109
Angiopoietin‐2 enhances retinal vessel sensitivity to vascular endothelial growth factor
Oshima, Y., Deering, T. G., Oshima, S. M., Nambu, H., Reddy, P. S., Kaleko, M., Connelly, S., Hackett, S. F., & Campochiaro, P. A. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10442 · Cited by 108
Self-citationPechan, P., Rubin, H., Lukason, M., Ardinger, J., DuFresne, E., Hauswirth, W. W., Wadsworth, S. C., & Scaria, A. (2009) · Gene Therapy · doi:10.1038/gt.2008.115 · Cited by 104 · cited 1×
“Intravitreous injection of an AAV2 vector expressing a modified version of sFlt1 consisting of domain 2 of Flt1 linked to a human IgG Fc fragment (sFLT01), choroidal NV in primates (Lukason et al., 2011; Pechan et al., 2009).”
BackgroundHonda, M., Sakamoto, T., Ishibashi, T., Inomata, H., & Ueno, H. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301203 · Cited by 103
Campochiaro, P. A., Sophie, R., Tolentino, M., Miller, D. M., Browning, D. J., Boyer, D. S., Heier, J. S., Gambino, L., Withers, B., Brigell, M., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.09.023 · Cited by 100
Self-citationOshima, Y., Oshima, S., Nambu, H., Kachi, S., Hackett, S., Melia, M., Kaleko, M., Connelly, S., Esumi, N., Zack, D. J., et al. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20110 · Cited by 100
Self-citationVinores, S. A., Xiao, W., Aslam, S., Shen, J., Oshima, Y., Nambu, H., Liu, H., Carmeliet, P., & Campochiaro, P. A. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20525 · Cited by 99 · cited 1×
“Mice in which the HRE has been removed from the Vegf promoter have marked reduction of ischemia-induced retinal NV and choroidal NV at Bruch's membrane rupture sites (Vinores et al., 2006).”
BackgroundSelf-citationMori, K., Gehlbach, P. L., Ando, A., Dyer, G., Lipinsky, E., Chaudhry, A., Hackett, S. F., & Campochiaro, P. A. (2002) · PubMed · Cited by 91
Self-citationLukason, M., DuFresne, E., Rubin, H. L., Pechan, P. A., Li, Q., Kim, I. K., Kiss, S., Flaxel, C. J., Collins, M., Miller, J. W., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.230 · Cited by 88
Seo, M. S., Okamoto, N., Vinores, M. A., Vinores, S. A., Hackett, S. F., Yamada, H., Yamada, E., Derevjanik, N. L., LaRochelle, W. J., Zack, D. J., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64612-3 · Cited by 86
Self-citationCampochiaro, P. A., & Hackett, S. F. (1993) · Experimental Eye Research · doi:10.1006/exer.1993.1158 · Cited by 85
Self-citationUmeda, N., Kachi, S., Akiyama, H., Zahn, G., Vossmeyer, D., Stragies, R., & Campochiaro, P. A. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020941 · Cited by 81
Self-citationIgarashi, T., Miyake, K., Kato, K., Watanabe, A., Ishizaki, M., Ohara, K., & Shimada, T. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301878 · Cited by 75
Sustained delivery of a HIF-1 antagonist for ocular neovascularization
Iwase, T., Fu, J., Yoshida, T., Muramatsu, D., Miki, A., Hashida, N., Lu, L., Oveson, B. C., Silva, R. L. E., Seidel, C. P., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.008 · Cited by 75
Self-citationDong, A., Seidel, C. P., Snell, D. C., Ekawardhani, S., Ahlskog, J., Baumann, M. J., Shen, J., Iwase, T., Tian, J., Stevens, R., et al. (2013) · Angiogenesis · doi:10.1007/s10456-013-9402-5 · Cited by 69
Self-citationIn Vivo Immunostaining Demonstrates Macrophages Associate with Growing and Regressing Vessels
Shen, J., Xie, B., Dong, A., Swaim, M., Hackett, S. F., & Campochiaro, P. A. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0113 · Cited by 65
Self-citationUeno, S., Pease, M. E., Wersinger, D. M. B., Masuda, T., Vinores, S. A., Licht, T., Zack, D. J., Quigley, H., Keshet, E., & Campochiaro, P. A. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21445 · Cited by 60
Self-citationBalaggan, K. S., Binley, K. E., Esapa, M., MacLaren, R. E., Iqball, S., Durán, Y., Pearson, R. A., Kan, O., Barker, S. E., Smith, A. J., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302769 · Cited by 59
Nambu, H., Umeda, N., Kachi, S., Oshima, Y., Akiyama, H., Nambu, R., & Campochiaro, P. A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20292 · Cited by 56
Self-citationChanna, R., Sophie, R., Bagheri, S., Shah, S. M., Wang, J., Adeyemo, O., Sodhi, A., Wenick, A. S., Ying, H. S.-C., & Campochiaro, P. A. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.09.012 · Cited by 55
Self-citationMarked inhibition of retinal neovascularization in rats following soluble‐flt‐1 gene transfer
Rota, R., Riccioni, T., Zaccarini, M., Lamartina, S., Gallo, A. D., Fusco, A., Kovesdi, I., Balestrazzi, E., ABENI, D. D., Ali, R. R., et al. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.586 · Cited by 53
Ocular versus Extraocular Neovascularization: Mirror Images or Vague Resemblances
Campochiaro, P. A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1494 · Cited by 50
Self-citationKachi, S., Binley, K., Yokoi, K., Umeda, N., Akiyama, H., Muramatu, D., Iqball, S., Kan, O., Naylor, S., & Campochiaro, P. A. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.046 · Cited by 45
Self-citationTyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells
Yacyshyn, O. K., Lai, P. F. H., Forse, K., Teichert-Kuliszewska, K., Jurasz, P., & Stewart, D. J. (2009) · Angiogenesis · doi:10.1007/s10456-008-9126-0 · Cited by 30
Boyer, D. S. (2009) · Investigative Ophthalmology & Visual Science · Cited by 22
Boyer, D. S., Goldbaum, M., LEYS, A. M., Starita, C., & for the V.I.S.I.O.N. Study Group (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304075 · Cited by 22
Oshima, Y., Takahashi, K., Oshima, S. M., Saishin, Y., Saishin, Y., Silva, R. L., Liang, X., Reddy, P. S., Ganesh, S., Brann, T. W., et al. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10441 · Cited by 20
Self-citation(2002) · Molecular Therapy · doi:10.1016/s1525-0016(16)43601-4 · Cited by 15
Kachi, S., Binley, K., Yokoi, K., Umeda, N., Akiyama, H., Igball, S., Kan, O., Naylor, S., & Campochiaro, P. A. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.046 · Cited by 5
Self-citation
Cited by
Kashani, A. H., Chen, C.-L., Gahm, J. K., Zheng, F., Richter, G. M., Rosenfeld, P. J., Shi, Y., & Wang, R. K. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.07.002 · Cited by 1,006
Heier, J. S., Khanani, A. M., Quezada Ruiz, C., Basu, K., Ferrone, P. J., Brittain, C., Figueroa, M. S., Lin, H., Holz, F. G., Patel, V., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00010-1 · Cited by 785
Self-citationPharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Blood vessel segmentation algorithms — Review of methods, datasets and evaluation metrics
Moccia, S., De Momi, E., El Hadji, S., & Mattos, L. S. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.02.001 · Cited by 567
Metadata
- Authors
- Campochiaro, P. A.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 49
- Pages
- 67-81
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W763617670
- Cited by
- 545
- References
- 127
- FWCI
- 33.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.